7Heinemann V,Boeck S,Hinke A,Labianca R,Louvet C.Meta-analysis of randomized trials:evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.BMC Cancer2008;8:82.
8Sultana A,Tudur Smith C,Cunningham D,Starling N,Ne-optolemos JP,Ghaneh P.Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer:re-sults of secondary end points analyses.Br J Cancer2008;99:6-13.
2Auyang S Y.复杂系统理论基础[M].田宝国,周亚,樊瑛,译.上海:上海科技教育出版社,2003:1-419.
3Mok T, Wu YL, Thongprasert S, et al. Phase III, randomized, open-label, first-line study of gefitinib vs carboplatin/ paclitaxel in clinically selected patients with advanced non- small cell lung cancer (IPASS)[J]. Ann Oncol, 2008, 19(Suppl 8):aLBA2.
4Lordick F, Leon-Chong J, Kang Y, et al. Her2 status of advanced gastric cancer is similar in Europe and Asia[J]. Ann Oncol, 2007, 18(Suppl 7):253.
5Fujimoto-Ouchi K, Sekiguchi F, Yasuno H, et al. Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models[J]. Cancer Chemother Pharmacol, 2007, 59(6):795-805.
6Cortes-Funes H, Rivera F, Ales I, et al. Phase II of trastuzumab and cisplatin in patients (pts) with advanced gastric cancer (AGC) with HER2/neu overexpression/amplification[J]. J Clin Oncol, 2007, 25(18S):4613.
